We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Bodisen | LSE:BODI | London | Ordinary Share | COM STK USD0.0001 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 6.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMBODI
RNS Number : 6572A
Bodisen Biotech Inc
24 December 2014
24 December 2014
Bodisen Biotech, Inc.
("Bodisen" or the "Company")
Cancellation of Admission to Trading on AIM
Bodisen announced on 24 June 2014 that the Company had been unable to publish its audited results for the year ended 31 December 2013 and accordingly, the Company's ordinary shares were suspended from trading on AIM.
The Company remains unable to confirm when the audit for the year to 31 December 2013 will be completed or when the accounts will be published.
As a result, and in accordance with AIM Rule 41, admission of the Company's shares to trading AIM will be cancelled on 29 December 2014 at which point the Company's shares will have been suspended from trading for six months.
Bodisen shares continue to be traded on the OTC market in the United States (ticker: BBCZ).
Charles Stanley Securities confirms that it will resign as the Company's Nominated Adviser and Broker with effect from 29 December 2014.
Enquiries:
Bodisen Biotech, Inc.
Lin Wang 0086 29 8707 4957
Charles Stanley Securities
(Nominated Adviser)
Russell Cook / Carl Holmes 020 7149 6000
This information is provided by RNS
The company news service from the London Stock Exchange
END
STRPGGMPPUPCGMW
1 Year Bodisen Biotech Chart |
1 Month Bodisen Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
